197 related articles for article (PubMed ID: 6944530)
21. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
[TBL] [Abstract][Full Text] [Related]
22. Fc receptor-bearing peripheral blood mononuclear cells in breast cancer patients: a possible marker of tumour burden and prognosis.
Bray J; McPherson TA
Clin Exp Immunol; 1981 Jun; 44(3):629-37. PubMed ID: 7035033
[TBL] [Abstract][Full Text] [Related]
23. Immunological activity of regional lymph nodes in tumor-bearing mice.
Barna BP; Deodhar SD
Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated cytotoxicity of mononuclear cells isolated from cancer and normal mucosa of the stomach.
Sakai Y; Koizumi K
Gastroenterology; 1982 Jun; 82(6):1374-80. PubMed ID: 7067957
[TBL] [Abstract][Full Text] [Related]
25. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
[TBL] [Abstract][Full Text] [Related]
26. Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease.
Britton S; Eklund AE; Bird AG
Gastroenterology; 1978 Aug; 75(2):218-20. PubMed ID: 669207
[TBL] [Abstract][Full Text] [Related]
27. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
29. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
[TBL] [Abstract][Full Text] [Related]
30. Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer.
Ehi K; Ishigami S; Masamoto I; Uenosono Y; Natsugoe S; Arigami T; Arima H; Kijima Y; Yoshinaka H; Yanagita S; Kozono T; Funasako Y; Maruyama I; Aikou T
Oncol Rep; 2008 Mar; 19(3):601-7. PubMed ID: 18288390
[TBL] [Abstract][Full Text] [Related]
31. Circulating killer cells in women undergoing needle-directed excisional breast biopsy.
Ohlsson-Wilhelm BM; Wang G
Eur J Histochem; 1994; 38 Suppl 1():77-82. PubMed ID: 8547715
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the natural cell mediated and antibody dependent cell mediated cytotoxicity measured as a function of target cell number in patients with mammary tumors and healthy female blood donors.
Bakaćs T; Garam T; Ringwald G; Tótpál K; Svastits E
Arch Geschwulstforsch; 1981; 51(4):327-37. PubMed ID: 7316684
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells are dysfunctional in patients with operable breast cancer.
Satthaporn S; Robins A; Vassanasiri W; El-Sheemy M; Jibril JA; Clark D; Valerio D; Eremin O
Cancer Immunol Immunother; 2004 Jun; 53(6):510-8. PubMed ID: 14740176
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to guided imagery during breast cancer treatment.
Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
Kubo M; Morisaki T; Matsumoto K; Tasaki A; Yamanaka N; Nakashima H; Kuroki H; Nakamura K; Nakamura M; Katano M
Cancer Immunol Immunother; 2005 May; 54(5):468-76. PubMed ID: 15592829
[TBL] [Abstract][Full Text] [Related]
38. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
39. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
40. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]